Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein
- Author
- VERMA, Subodh1 ; LI, Shu-Hong1 ; BADIWALA, Mitesh V1 ; WEISEL, Richard D1 ; FEDAK, Paul W. M1 ; LI, Ren-Ke1 ; DHILLON, Bikramjit1 ; MICKLE, Donald A. G1
[1] Division of Cardiac Surgery, Toronto General Hospital Research Institute, University of Toronto, Canada - Source
Circulation (New York, N.Y.). 2002, Vol 105, Num 16, pp 1890-1896 ; ref : 33 ref
- CODEN
- CIRCAZ
- ISSN
- 0009-7322
- Scientific domain
- Cardiology, blood circulation, phlebology
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Adhérence Athérosclérose Endothéline 1 Homme Interleukine 6 Pathogénie Protéine C réactive Protéine ICAM1 Protéine VCAM1 Appareil circulatoire pathologie Vaisseau sanguin pathologie
- Keyword (en)
- Adhesion Atherosclerosis Endothelin 1 Human Interleukin 6 Pathogenesis C reactive protein Intercellular adhesion molecule 1 Vascular cell adhesion molecule 1 Cardiovascular disease Vascular disease
- Keyword (es)
- Adherencia Ateroesclerosis Endothelina 1 Hombre Interleuquina 6 Patogenia Proteína reactiva Proteína ICAM1 Proteína VCAM1 Aparato circulatorio patología Vaso sanguíneo patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12B Blood and lymphatic vessels / 002B12B01 Atherosclerosis (general aspects, experimental research)
- Discipline
- Cardiology. Circulatory system
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13642541
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1161/01.CIR.0000015126.83143.B4 
https://dx.doi.org/10.1161/01.CIR.0000015126.83143.B4
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1161\/01.CIR.0000015126.83143.B4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"105\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"1890\";s:8:\"\u0000*\u0000epage\";s:4:\"1896\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VERMA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Subodh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"LI, Shu-Hong\";i:1;s:18:\"BADIWALA, Mitesh V\";i:2;s:17:\"WEISEL, Richard D\";i:3;s:16:\"FEDAK, Paul W. M\";i:4;s:10:\"LI, Ren-Ke\";i:5;s:18:\"DHILLON, Bikramjit\";i:6;s:19:\"MICKLE, Donald A. G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:109:\"Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1161\/01.CIR.0000015126.83143.B4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"105\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"1890\";s:8:\"\u0000*\u0000epage\";s:4:\"1896\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VERMA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Subodh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"LI, Shu-Hong\";i:1;s:18:\"BADIWALA, Mitesh V\";i:2;s:17:\"WEISEL, Richard D\";i:3;s:16:\"FEDAK, Paul W. M\";i:4;s:10:\"LI, Ren-Ke\";i:5;s:18:\"DHILLON, Bikramjit\";i:6;s:19:\"MICKLE, Donald A. G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:109:\"Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:34:\"10.1161\/01.CIR.0000015126.83143.B4\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1161\/01.CIR.0000015126.83143.B4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"105\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"1890\";s:8:\"\u0000*\u0000epage\";s:4:\"1896\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VERMA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Subodh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"LI, Shu-Hong\";i:1;s:18:\"BADIWALA, Mitesh V\";i:2;s:17:\"WEISEL, Richard D\";i:3;s:16:\"FEDAK, Paul W. M\";i:4;s:10:\"LI, Ren-Ke\";i:5;s:18:\"DHILLON, Bikramjit\";i:6;s:19:\"MICKLE, Donald A. G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:109:\"Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1161\/01.CIR.0000015126.83143.B4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"105\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"1890\";s:8:\"\u0000*\u0000epage\";s:4:\"1896\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VERMA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Subodh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"LI, Shu-Hong\";i:1;s:18:\"BADIWALA, Mitesh V\";i:2;s:17:\"WEISEL, Richard D\";i:3;s:16:\"FEDAK, Paul W. M\";i:4;s:10:\"LI, Ren-Ke\";i:5;s:18:\"DHILLON, Bikramjit\";i:6;s:19:\"MICKLE, Donald A. G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:109:\"Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1161\/01.CIR.0000015126.83143.B4\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:109:\"Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:3:\"105\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"1890\";s:8:\"\u0000*\u0000epage\";s:4:\"1896\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VERMA\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Subodh\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"LI, Shu-Hong\";i:1;s:18:\"BADIWALA, Mitesh V\";i:2;s:17:\"WEISEL, Richard D\";i:3;s:16:\"FEDAK, Paul W. M\";i:4;s:10:\"LI, Ren-Ke\";i:5;s:18:\"DHILLON, Bikramjit\";i:6;s:19:\"MICKLE, Donald A. G\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:109:\"Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
